Home POP Biotechnologies

POP Biotechnologies

In operation
-
Vaccine Developer
Basic
Enterprise Profile

Basic Information

POP Biotechnologies, Inc. (POP BIO) is dedicated to addressing critical medical challenges using advanced nanotechnology, with a focus on the research and development of new therapies and vaccines. The PoP technology, exclusively licensed by the Research Foundation for the State University of New York (SUNY-RF), was developed by the company's founder, Dr. Jonathan Lovell, within his academic institution at the State University of New York in Buffalo (SUNY Buffalo).
POP Biotechnologies, Inc.
NewYork,United States of America
less than 15 people
January 01, 2015
--

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy Vaccine Formulation Production Biological Product Manufacturing
Technology
Immunological Techniques
Concept
Tumor Infectious Diseases
Application Scenarios
Traditional Vaccines (Biological Products for Prevention) Nanotechnology Novel Coronavirus